Christopher Kenney

Christopher Kenney

Company: Xenon Pharmaceuticals

Job title: Chief Medical Officer

Seminars:

Progressing from Treatment Resistant Depression with Novel Impactful Therapeutics 8:15 am

Expanding on the role of alternative receptors and allosteric modulation in therapeutic options Uncovering updates from research to predict drug response patterns How can patients with depression be stratified to streamline treatment decisions?Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.